Article By:
Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EST
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.